The global CRISPR And CRISPR-Associated Genes market size was valued at US$ 1354.3 million in 2023. With growing demand in downstream market, the CRISPR And CRISPR-Associated Genes is forecast to a readjusted size of US$ 1738.3 million by 2030 with a CAGR of 3.6% during review period.
The research report highlights the growth potential of the global CRISPR And CRISPR-Associated Genes market. CRISPR And CRISPR-Associated Genes are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of CRISPR And CRISPR-Associated Genes. 麻豆原创 players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the CRISPR And CRISPR-Associated Genes market.
This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.
Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.
The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.
Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.
By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.
Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.
CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.
Key Features:
The report on CRISPR And CRISPR-Associated Genes market reflects various aspects and provide valuable insights into the industry.
麻豆原创 Size and Growth: The research report provide an overview of the current size and growth of the CRISPR And CRISPR-Associated Genes market. It may include historical data, market segmentation by Type (e.g., Genome Editing, Genetic Engineering), and regional breakdowns.
麻豆原创 Drivers and Challenges: The report can identify and analyse the factors driving the growth of the CRISPR And CRISPR-Associated Genes market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the CRISPR And CRISPR-Associated Genes market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the CRISPR And CRISPR-Associated Genes industry. This include advancements in CRISPR And CRISPR-Associated Genes technology, CRISPR And CRISPR-Associated Genes new entrants, CRISPR And CRISPR-Associated Genes new investment, and other innovations that are shaping the future of CRISPR And CRISPR-Associated Genes.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the CRISPR And CRISPR-Associated Genes market. It includes factors influencing customer ' purchasing decisions, preferences for CRISPR And CRISPR-Associated Genes product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the CRISPR And CRISPR-Associated Genes market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting CRISPR And CRISPR-Associated Genes market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the CRISPR And CRISPR-Associated Genes market.
麻豆原创 Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the CRISPR And CRISPR-Associated Genes industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the CRISPR And CRISPR-Associated Genes market.
麻豆原创 Segmentation:
CRISPR And CRISPR-Associated Genes market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Segmentation by type
Genome Editing
Genetic Engineering
GRNA Database/Gene Librar
CRISPR Plasmid
Human Stem Cells
Genetically Modified Organisms/Crops
Cell Line Engineering
Segmentation by application
Biotechnology Companies
Pharmaceutical Companies
Academic Institutes
Research and Development Institutes
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Editas Medicine
Caribou Biosciences
CRISPR therapeutics
Intellia therapeutics, Inc.
Cellectis
Horizon Discovery Plc
Sigma Aldrich
Precision Biosciences
Genscript
Sangamo Biosciences Inc.
Lonza Group Limited
Integrated DNA Technologies
New England Biolabs
Origene Technologies
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global CRISPR And CRISPR-Associated Genes 麻豆原创 Size 2019-2030
2.1.2 CRISPR And CRISPR-Associated Genes 麻豆原创 Size CAGR by Region 2019 VS 2023 VS 2030
2.2 CRISPR And CRISPR-Associated Genes Segment by Type
2.2.1 Genome Editing
2.2.2 Genetic Engineering
2.2.3 GRNA Database/Gene Librar
2.2.4 CRISPR Plasmid
2.2.5 Human Stem Cells
2.2.6 Genetically Modified Organisms/Crops
2.2.7 Cell Line Engineering
2.3 CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Type
2.3.1 CRISPR And CRISPR-Associated Genes 麻豆原创 Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global CRISPR And CRISPR-Associated Genes 麻豆原创 Size 麻豆原创 Share by Type (2019-2024)
2.4 CRISPR And CRISPR-Associated Genes Segment by Application
2.4.1 Biotechnology Companies
2.4.2 Pharmaceutical Companies
2.4.3 Academic Institutes
2.4.4 Research and Development Institutes
2.5 CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Application
2.5.1 CRISPR And CRISPR-Associated Genes 麻豆原创 Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global CRISPR And CRISPR-Associated Genes 麻豆原创 Size 麻豆原创 Share by Application (2019-2024)
3 CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Player
3.1 CRISPR And CRISPR-Associated Genes 麻豆原创 Size 麻豆原创 Share by Players
3.1.1 Global CRISPR And CRISPR-Associated Genes Revenue by Players (2019-2024)
3.1.2 Global CRISPR And CRISPR-Associated Genes Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global CRISPR And CRISPR-Associated Genes Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CRISPR And CRISPR-Associated Genes by Regions
4.1 CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Regions (2019-2024)
4.2 Americas CRISPR And CRISPR-Associated Genes 麻豆原创 Size Growth (2019-2024)
4.3 APAC CRISPR And CRISPR-Associated Genes 麻豆原创 Size Growth (2019-2024)
4.4 Europe CRISPR And CRISPR-Associated Genes 麻豆原创 Size Growth (2019-2024)
4.5 Middle East & Africa CRISPR And CRISPR-Associated Genes 麻豆原创 Size Growth (2019-2024)
5 Americas
5.1 Americas CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Country (2019-2024)
5.2 Americas CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Type (2019-2024)
5.3 Americas CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Region (2019-2024)
6.2 APAC CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Type (2019-2024)
6.3 APAC CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe CRISPR And CRISPR-Associated Genes by Country (2019-2024)
7.2 Europe CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Type (2019-2024)
7.3 Europe CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa CRISPR And CRISPR-Associated Genes by Region (2019-2024)
8.2 Middle East & Africa CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Type (2019-2024)
8.3 Middle East & Africa CRISPR And CRISPR-Associated Genes 麻豆原创 Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.1 Global CRISPR And CRISPR-Associated Genes Forecast by Regions (2025-2030)
10.1.1 Global CRISPR And CRISPR-Associated Genes Forecast by Regions (2025-2030)
10.1.2 Americas CRISPR And CRISPR-Associated Genes Forecast
10.1.3 APAC CRISPR And CRISPR-Associated Genes Forecast
10.1.4 Europe CRISPR And CRISPR-Associated Genes Forecast
10.1.5 Middle East & Africa CRISPR And CRISPR-Associated Genes Forecast
10.2 Americas CRISPR And CRISPR-Associated Genes Forecast by Country (2025-2030)
10.2.1 United States CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.2.2 Canada CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.2.3 Mexico CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.2.4 Brazil CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.3 APAC CRISPR And CRISPR-Associated Genes Forecast by Region (2025-2030)
10.3.1 China CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.3.2 Japan CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.3.3 Korea CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.3.4 Southeast Asia CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.3.5 India CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.3.6 Australia CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.4 Europe CRISPR And CRISPR-Associated Genes Forecast by Country (2025-2030)
10.4.1 Germany CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.4.2 France CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.4.3 UK CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.4.4 Italy CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.4.5 Russia CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.5 Middle East & Africa CRISPR And CRISPR-Associated Genes Forecast by Region (2025-2030)
10.5.1 Egypt CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.5.2 South Africa CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.5.3 Israel CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.5.4 Turkey CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.5.5 GCC Countries CRISPR And CRISPR-Associated Genes 麻豆原创 Forecast
10.6 Global CRISPR And CRISPR-Associated Genes Forecast by Type (2025-2030)
10.7 Global CRISPR And CRISPR-Associated Genes Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Information
11.1.2 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Product Offered
11.1.3 Thermo Fisher Scientific CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.1.4 Thermo Fisher Scientific Main Business Overview
11.1.5 Thermo Fisher Scientific Latest Developments
11.2 Editas Medicine
11.2.1 Editas Medicine Company Information
11.2.2 Editas Medicine CRISPR And CRISPR-Associated Genes Product Offered
11.2.3 Editas Medicine CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.2.4 Editas Medicine Main Business Overview
11.2.5 Editas Medicine Latest Developments
11.3 Caribou Biosciences
11.3.1 Caribou Biosciences Company Information
11.3.2 Caribou Biosciences CRISPR And CRISPR-Associated Genes Product Offered
11.3.3 Caribou Biosciences CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.3.4 Caribou Biosciences Main Business Overview
11.3.5 Caribou Biosciences Latest Developments
11.4 CRISPR therapeutics
11.4.1 CRISPR therapeutics Company Information
11.4.2 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Product Offered
11.4.3 CRISPR therapeutics CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.4.4 CRISPR therapeutics Main Business Overview
11.4.5 CRISPR therapeutics Latest Developments
11.5 Intellia therapeutics, Inc.
11.5.1 Intellia therapeutics, Inc. Company Information
11.5.2 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Product Offered
11.5.3 Intellia therapeutics, Inc. CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.5.4 Intellia therapeutics, Inc. Main Business Overview
11.5.5 Intellia therapeutics, Inc. Latest Developments
11.6 Cellectis
11.6.1 Cellectis Company Information
11.6.2 Cellectis CRISPR And CRISPR-Associated Genes Product Offered
11.6.3 Cellectis CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.6.4 Cellectis Main Business Overview
11.6.5 Cellectis Latest Developments
11.7 Horizon Discovery Plc
11.7.1 Horizon Discovery Plc Company Information
11.7.2 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Product Offered
11.7.3 Horizon Discovery Plc CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.7.4 Horizon Discovery Plc Main Business Overview
11.7.5 Horizon Discovery Plc Latest Developments
11.8 Sigma Aldrich
11.8.1 Sigma Aldrich Company Information
11.8.2 Sigma Aldrich CRISPR And CRISPR-Associated Genes Product Offered
11.8.3 Sigma Aldrich CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.8.4 Sigma Aldrich Main Business Overview
11.8.5 Sigma Aldrich Latest Developments
11.9 Precision Biosciences
11.9.1 Precision Biosciences Company Information
11.9.2 Precision Biosciences CRISPR And CRISPR-Associated Genes Product Offered
11.9.3 Precision Biosciences CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.9.4 Precision Biosciences Main Business Overview
11.9.5 Precision Biosciences Latest Developments
11.10 Genscript
11.10.1 Genscript Company Information
11.10.2 Genscript CRISPR And CRISPR-Associated Genes Product Offered
11.10.3 Genscript CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.10.4 Genscript Main Business Overview
11.10.5 Genscript Latest Developments
11.11 Sangamo Biosciences Inc.
11.11.1 Sangamo Biosciences Inc. Company Information
11.11.2 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Product Offered
11.11.3 Sangamo Biosciences Inc. CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.11.4 Sangamo Biosciences Inc. Main Business Overview
11.11.5 Sangamo Biosciences Inc. Latest Developments
11.12 Lonza Group Limited
11.12.1 Lonza Group Limited Company Information
11.12.2 Lonza Group Limited CRISPR And CRISPR-Associated Genes Product Offered
11.12.3 Lonza Group Limited CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.12.4 Lonza Group Limited Main Business Overview
11.12.5 Lonza Group Limited Latest Developments
11.13 Integrated DNA Technologies
11.13.1 Integrated DNA Technologies Company Information
11.13.2 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Product Offered
11.13.3 Integrated DNA Technologies CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.13.4 Integrated DNA Technologies Main Business Overview
11.13.5 Integrated DNA Technologies Latest Developments
11.14 New England Biolabs
11.14.1 New England Biolabs Company Information
11.14.2 New England Biolabs CRISPR And CRISPR-Associated Genes Product Offered
11.14.3 New England Biolabs CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.14.4 New England Biolabs Main Business Overview
11.14.5 New England Biolabs Latest Developments
11.15 Origene Technologies
11.15.1 Origene Technologies Company Information
11.15.2 Origene Technologies CRISPR And CRISPR-Associated Genes Product Offered
11.15.3 Origene Technologies CRISPR And CRISPR-Associated Genes Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
11.15.4 Origene Technologies Main Business Overview
11.15.5 Origene Technologies Latest Developments
12 Research Findings and Conclusion
听
听
*If Applicable.
